About Crescent Pharmaceutical Group
Crescent Pharmaceutical Group is one of the UK's leading independent pharmaceutical businesses, bringing together pharmaceutical development, manufacturing, quality, regulatory expertise, supply chain management and commercial operations through a connected network of UK and international businesses.
By combining UK operations with global in-house development and manufacturing capabilities, alongside carefully selected strategic development and manufacturing partners, we provide the expertise, flexibility and resilience needed to deliver a dependable supply of high-quality generic medicines to healthcare providers.
For more than two decades, our business has continued to invest in scientific capability, manufacturing infrastructure, regulatory excellence and long-term partnerships that strengthen medicine supply across the UK and international markets.
With over 850 UK Marketing Authorisations, more than 500 products in active development, four UK manufacturing sites, over 250 million packs supplied annually, and an ambition to build a 1,000-product portfolio by 2030, Crescent continues to strengthen its position as a trusted partner to the NHS, pharmacies, wholesalers and healthcare providers by investing in sustainable growth, operational excellence and resilient supply chains.
BUILDING FOR THE FUTURE
Our Strategy
Our long-term strategy is focused on strengthening every aspect of the pharmaceutical value chain. Through continuous investment, scientific expertise and operational excellence, we are building a stronger, more resilient pharmaceutical group capable of supporting healthcare providers today and into the future.
We are committed to expanding our product portfolio, strengthening UK manufacturing, investing in people and technology, and building resilient supply chains that support the NHS, pharmacies, hospitals, wholesalers and healthcare providers across the UK and international markets.
Expand Our Portfolio
We continue to broaden our portfolio through in-house development, strategic acquisitions and new product launches, increasing access to high-quality generic medicines across the UK and international markets.
Strengthen Manufacturing Capability
Investment in UK manufacturing, global in-house production and carefully selected manufacturing partners provides the flexibility, capacity and resilience needed to support long-term medicine supply.
Supporting UK Healthcare
We continue to invest in UK pharmaceutical infrastructure, strengthening manufacturing, development, warehousing and nationwide distribution to help support a resilient medicines supply chain for the NHS and healthcare providers.
Investing in Tomorrow
Investment in research, product development, manufacturing and regulatory expertise enables us to introduce new medicines, support complex products and strengthen our long-term scientific capability.
Our UK Presence
Headquartered in Basingstoke, Crescent Pharmaceutical Group operates an integrated network of offices, manufacturing facilities, warehousing and distribution centres across the United Kingdom. With operations in Basingstoke, Andover, Bolton, Mablethorpe and London, our nationwide infrastructure supports every stage of the pharmaceutical lifecycle.
Our Mission
At Crescent Pharmaceutical Group, our mission is to improve patient access to high-quality, affordable medicines by combining pharmaceutical innovation, manufacturing excellence and reliable supply.
We are committed to expanding our product portfolio, strengthening UK manufacturing, investing in people and technology, and building resilient supply chains that support the NHS, pharmacies, hospitals, wholesalers and healthcare providers across the UK and international markets.
Expand Patient Access
We are committed to increasing patient access to high-quality, affordable medicines by expanding our portfolio, strengthening availability and supporting every major healthcare channel. Through close partnerships with the NHS, pharmacies, hospitals, wholesalers and international distributors, we work to ensure patients have reliable access to the medicines they depend upon.
Supporting UK Healthcare
As a UK-based pharmaceutical group, we are committed to strengthening the resilience of the UK's medicines supply chain. Through continued investment in UK manufacturing, pharmaceutical development, warehousing and nationwide distribution, we help ensure patients have reliable access to high-quality, affordable medicines. By working closely with the NHS, pharmacies, hospitals, wholesalers and healthcare providers, we support the delivery of medicines where they are needed most.
Driving Innovation & Sustainable Growth
Innovation is at the heart of our long-term strategy. We continue to invest in pharmaceutical development, regulatory expertise, UK manufacturing, digital technologies and strategic acquisitions to expand our capabilities and accelerate growth. With over 500 products in active development and ongoing investment in infrastructure and technology, we are building a stronger, more agile pharmaceutical group ready to meet the healthcare challenges of tomorrow.
Strengthen Healthcare Partnerships
We believe strong partnerships create stronger healthcare systems. By working collaboratively with the NHS, healthcare providers, pharmacy groups, wholesalers, suppliers and international manufacturing partners, we deliver high-quality medicines, dependable service and resilient supply solutions that create long-term value for our customers and patients alike.
Integrated Pharmaceutical Solutions
Crescent Pharmaceutical Group operates as a pharmaceutical group of complementary businesses, each contributing specialist expertise across the medicine lifecycle. From product development and regulatory strategy through to commercial manufacturing, quality oversight, licensed distribution and market supply, our capabilities are designed to work together to support reliable access to medicines.
Alongside our UK operations, we have established global in-house pharmaceutical development and manufacturing capabilities, complemented by a carefully managed network of qualified contract development and manufacturing partners. This balanced operating model strengthens supply chain resilience, expands technical capability and supports long-term business continuity without compromising quality or regulatory oversight.
Today, Crescent continues to grow through strategic investment, portfolio expansion and the development of new scientific and manufacturing capabilities, ensuring we remain well positioned to support the evolving needs of healthcare providers and patients.
Manufacturing Network
Our integrated manufacturing network combines UK production facilities with long-standing partnerships across a global network of approved contract manufacturers. This approach enables us to produce a diverse range of high-quality generic medicines, increase manufacturing resilience and maintain reliable supply for the NHS, pharmacies, wholesalers and international markets.
Regulatory Compliance
Our regulatory expertise is fundamental to delivering reliable generic medicines. From product development and licensing through to lifecycle management, we work to ensure our medicines comply with UK and international regulatory requirements.
Delivering Value
We combine efficient manufacturing, strategic sourcing and integrated supply chain management to deliver high-quality generic medicines at competitive prices. By continually improving our operations and investing in scalable infrastructure, we help make medicines more affordable while maintaining the quality, reliability and continuity of supply expected by healthcare providers and patients.
Packaging and Labelling
Our packaging and labelling processes are designed to ensure every medicine is accurately presented, fully compliant and ready for safe patient use. Supported by rigorous quality controls and regulatory oversight, we provide clear product information, complete traceability and packaging that meets the highest standards of safety, quality and regulatory compliance.
Research and Development
Research and development are central to our growth strategy. We combine in-house scientific expertise with trusted global development partnerships to build a strong pipeline of new generic medicines and Marketing Authorisations. Through continuous investment in innovation and product development, we expand our portfolio and help improve access to affordable medicines across the UK and international markets.
Quality Assurance
Quality is embedded throughout every stage of our operations. From raw material approval and in-process controls to finished product testing and batch certification, our comprehensive quality systems help ensure every medicine consistently meets the highest standards of quality, safety and performance. Products are tested by UK and EU approved laboratories before release, providing confidence to healthcare professionals and patients alike.
Supply Chain Excellence
We operate an integrated supply chain that combines strategic sourcing, approved global manufacturing partnerships, UK warehousing and intelligent inventory management to support the reliable supply of medicines. By investing in supply resilience, dual sourcing and efficient logistics, we help ensure continuity of supply for the NHS, pharmacies, wholesalers, hospitals and international customers.
Integrated Distribution
Our integrated distribution network combines UK warehousing, strategic stockholding and nationwide logistics to support the reliable supply of medicines across the healthcare sector. By optimising inventory, transportation and fulfilment, we help ensure high-quality medicines reach wholesalers, pharmacies, hospitals, the NHS and healthcare providers efficiently and on time.
Working with the NHS
Helping ensure patients have access to the medicines they need is at the heart of our business. Through close collaboration with the NHS, the Department of Health and healthcare partners, we support the reliable supply of affordable generic medicines across the UK. Our broad portfolio, resilient supply chain and UK infrastructure help strengthen continuity of supply, including the provision of more than 100 medicines to NHS hospitals.
At Crescent Pharmaceutical Group, we are committed to strengthening healthcare through the reliable supply of affordable, high-quality generic medicines. By integrating pharmaceutical development, manufacturing, regulatory expertise, quality assurance and resilient supply chain capabilities, we help ensure medicines reach the patients who need them, when they need them. Through continuous investment in innovation, UK infrastructure and operational excellence, we continue to support the NHS, healthcare providers and international partners while expanding access to medicines across the UK and beyond.
Committed to Quality
Crescent Pharmaceutical Group operates under the appropriate MHRA licences for the development, manufacture, importation and supply of medicines in the UK. Supported by robust quality systems, experienced regulatory teams and a culture of continuous compliance, we ensure our medicines consistently meet the highest standards of quality, safety and efficacy, providing confidence to healthcare professionals, patients and partners alike.
MHRA approved since 2003
Maintaining MHRA licences requires a continual commitment to quality, compliance and operational excellence. Crescent Pharmaceutical Group operates robust quality management systems, validated manufacturing processes and comprehensive quality controls that are regularly assessed through MHRA inspections. This ongoing regulatory oversight provides assurance that our medicines are developed, manufactured and supplied in accordance with the highest standards of Good Manufacturing Practice (GMP), quality and patient safety.
Evidence-Based Generic Medicines
Each Product and Marketing Authorisation is supported by comprehensive pharmaceutical, manufacturing and quality data, together with bioequivalence studies where required, demonstrating that our generic medicines meet the same rigorous standards of quality, safety and efficacy as the corresponding reference medicines. This scientific foundation enables healthcare professionals, patients and procurement organisations to have confidence in the consistency and reliability of every product within our portfolio.
Scientific & Regulatory Assessment
Every generic medicine undergoes independent third-party scientific and regulatory assessment before it is approved for supply. Regulatory authorities evaluate comprehensive pharmaceutical, manufacturing, quality and bioequivalence data to confirm that the medicine meets the same high standards of quality, safety and efficacy as the corresponding reference medicine. This independent assessment provides healthcare professionals, patients and procurement organisations with confidence in the reliability and therapeutic equivalence of approved generic medicines.
High Quality Products
Operating under MHRA and other applicable regulatory licences demonstrates Crescent Pharmaceutical Group's commitment to maintaining the highest standards of pharmaceutical quality, patient safety and regulatory compliance.